543616 Stock Overview
A pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Trident Lifeline Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹304.60 |
| 52 Week High | ₹339.00 |
| 52 Week Low | ₹136.00 |
| Beta | -0.20 |
| 11 Month Change | 1.87% |
| 3 Month Change | 12.03% |
| 1 Year Change | 71.85% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 181.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543616 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.0% | -3.1% | -3.4% |
| 1Y | 71.8% | 41.1% | 27.0% |
Return vs Industry: 543616 exceeded the Indian Pharmaceuticals industry which returned 42.9% over the past year.
Return vs Market: 543616 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 543616 volatility | |
|---|---|
| 543616 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543616 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543616's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 40 | Shravan Patel | www.tridentlifeline.com |
Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. It offers pharmaceutical products in the form of tablets, capsules, liquid orals, external preparations, gel, mouthwash, and lotion; and nutraceutical tablets, capsules, liquids, sachets, oral sprays, and effervescent tablets, as well as ice gels, pastes, solutions, suspension, syrup, cream, drypowders, and toothpastes. The company was incorporated in 2014 and is based in Surat, India.
Trident Lifeline Limited Fundamentals Summary
| 543616 fundamental statistics | |
|---|---|
| Market cap | ₹3.50b |
| Earnings (TTM) | ₹97.09m |
| Revenue (TTM) | ₹600.55m |
36.1x
P/E Ratio5.8x
P/S RatioIs 543616 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543616 income statement (TTM) | |
|---|---|
| Revenue | ₹600.55m |
| Cost of Revenue | ₹359.88m |
| Gross Profit | ₹240.67m |
| Other Expenses | ₹143.58m |
| Earnings | ₹97.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.44 |
| Gross Margin | 40.07% |
| Net Profit Margin | 16.17% |
| Debt/Equity Ratio | 39.6% |
How did 543616 perform over the long term?
See historical performance and comparison